Poster
Safety and pharmacokinetics of BLU-263, a next-generation KIT inhibitor, in healthy volunteers
Author
Nimita Dave
Condition
systemic mastocytosis
Drug target
KIT D816V
Drug moa
KIT D816V inhibitor
Source url
s3://convoke-optic-posters/2024-05-10/Blueprint-Medicines-AACR-2021-BLU-263-Healthy-Volunteers-Poster.pdf
2 organizations
1 product
Product
BLU-263Organization
Blueprint MedicinesOrganization
Celerion Inc